Constitutively active NFkappa B is required for the survival of S-type neuroblastoma (Q44116118)

29 November 2017

Constitutively active NFkappa B is required for the survival of S-type neuroblastoma (English)

1 reference

29 November 2017

Xin Bian

1

1 reference

29 November 2017

Anthony W Opipari

2

1 reference

29 November 2017

Anthony B Ratanaproeksa

3

1 reference

29 November 2017

Anthony E Boitano

4

1 reference

29 November 2017

Peter C Lucas

5

1 reference

29 November 2017

Valerie P Castle

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

26 August 2002

1 reference

Journal of Biological Chemistry

29 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

277

1 reference

29 November 2017

44

1 reference

29 November 2017

42144-42150

1 reference

Signal transduction through NF-kappa B.

29 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Effect of antineoplastic drugs on human leukocyte-mediated cytotoxicity against herpes simplex virus infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Role of multiple cellular proteases in the execution of programmed cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkappaB kinases containing IKKalpha and IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Characterization of Two Neuroblastoma Cell Lines Expressing Recombinant Nerve Growth Factor Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203891200

21 January 2018

Identifiers

DOI

10.1074/JBC.M203891200

1 reference

29 November 2017

1 reference